awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55021969-31F16E9B-0C89-4DA6-B7C6-2E1FC15889E1
Q55021969-31F16E9B-0C89-4DA6-B7C6-2E1FC15889E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55021969-31F16E9B-0C89-4DA6-B7C6-2E1FC15889E1
Usefulness of alirocumab and evolocumab for the treatment of patients with diabetic dyslipidemia.
P2860
Q55021969-31F16E9B-0C89-4DA6-B7C6-2E1FC15889E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55021969-31F16E9B-0C89-4DA6-B7C6-2E1FC15889E1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ffc5d214867d1b4c0aca12b21f907f35eedec42
P2860
The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2